272 research outputs found

    The “systems approach” to treating the brain: opportunities in developmental psychopharmacology

    Get PDF
    The significance of early life for the long-term programming of mental health is increasingly being recognized. However, most psychotropic medications are currently intended for adult patients, and early psychopharmacological approaches aimed at reverting aberrant neurodevelopmental trajectories are missing. Psychopharmacologic intervention at an early age faces the challenge of operating in a highly plastic system and requires a comprehensive knowledge of neurodevelopmental mechanisms. Recently the systems biology approach has contributed to the understanding of neuroplasticity mechanisms from a new perspective that interprets them as the result of complex and dynamic networks of signals from different systems. This approach is creating opportunities for developmental psychopharmacology, suggesting novel targets that can modulate the course of development by interfering with neuroplasticity at an early age. We will discuss two interconnected systems—the immune and gut microbiota—that regulate neurodevelopment and that have been implicated in preclinical research as new targets in the prevention of aberrant brain development

    Mass of the b-quark and B-decay constants from Nf=2+1+1 twisted-mass Lattice QCD

    Get PDF
    We present precise lattice computations for the b-quark mass, the quark mass ratios mb/mc and mb/ms as well as the leptonic B-decay constants. We employ gauge configurations with four dynamical quark flavors, up/down, strange and charm, at three values of the lattice spacing (a ~ 0.06 - 0.09 fm) and for pion masses as low as 210 MeV. Interpolation in the heavy quark mass to the bottom quark point is performed using ratios of physical quantities computed at nearby quark masses exploiting the fact that these ratios are exactly known in the static quark mass limit. Our results are also extrapolated to the physical pion mass and to the continuum limit and read: mb(MSbar, mb) = 4.26(10) GeV, mb/mc = 4.42(8), mb/ms = 51.4(1.4), fBs = 229(5) MeV, fB = 193(6) MeV, fBs/fB = 1.184(25) and (fBs/fB)/(fK/fpi) = 0.997(17).Comment: Version to appear in PRD. Added comments to simulation setup and error budget discussion. 1+20 pages, 9 figure

    Topiramat w profilaktyce migreny: dane uzyskane na podstawie analizy zbiorczej i otwartego badania obserwacyjnego

    Get PDF
    Topiramat zarejestrowano do profilaktycznego leczenia migreny w kilku krajach na podstawie wyników trzech dużych badań randomizowanych, przeprowadzonych metodą podwójnie ślepej próby, w których wykazano, że skuteczność tego leku była znacząco większa niż placebo. Autorzy dokonali przeglądu wyników dwóch badań. W jednym z nich wykorzystano połączone dane z trzech badań kontrolowanych, przeprowadzonych metodą podwójnie ślepej próby, w których stosowano topiramat w dawce 100 mg, natomiast drugie stanowi kontynuację dwóch z wymienionych badań, w formie otwartego badania obserwacyjnego, w którym pacjenci otrzymywali różne dawki topiramatu przez 8 miesięcy w ramach leczenia podtrzymującego. Uzyskane wyniki potwierdzają, że topiramat skutecznie zmniejsza częstość migrenowych bólów głowy i wykazuje korzystny profil bezpieczeństwa

    Trust, Identity, Privacy, and Security Considerations for Designing a Peer Data Sharing Platform Between People Living With HIV

    Get PDF
    Resulting from treatment advances, the Human Immunodeficiency Virus (HIV) is now a long-term condition, and digital solutions are being developed to support people living with HIV in self-management. Sharing their health data with their peers may support self-management, but the trust, identity, privacy and security (TIPS) considerations of people living with HIV remain underexplored. Working with a peer researcher who is expert in the lived experience of HIV, we interviewed 26 people living with HIV in the United Kingdom (UK) to investigate how to design a peer data sharing platform. We also conducted rating activities with participants to capture their attitudes towards sharing personal data. Our mixed methods study showed that participants were highly sophisticated in their understanding of trust and in their requirements for robust privacy and security. They indicated willingness to share digital identity attributes, including gender, age, medical history, health and well-being data, but not details that could reveal their personal identity. Participants called for TIPS measures to foster and to sustain responsible data sharing within their community. These findings can inform the development of trustworthy and secure digital platforms that enable people living with HIV to share data with their peers and provide insights for researchers who wish to facilitate data sharing in other communities with stigmatised health conditions

    Psychiatric screening for migraine patients

    Get PDF
    Psychiatric disorders in migraine patients have a higher prevalence than general population. The presence of psychiatric comorbidities may influence the complexity of the migraine pictures and be related to medication overuse. Severely impaired chronic migraineurs presenting with medication overuse are a challenge for headache clinics. Psychiatric comorbities, such as dependency-like behaviors, anxiety and mood symptoms, might account for headache-related disability and recurrent relapses into medication overuse after a successful detoxification. Within a sample of 63 chronic migraineurs with medication overuse and severe disability, we investigated to which extent clinical severity, affective states and attitudes about medication impact the overall functioning at time of detoxification. To unravel whether some of these factors could predict their long-term outcome, we followed and retest them 1 year after withdrawal. We hypothesized that the detoxification would have led to a partial improvement and not modified the attitudes toward medication and dependence. Detoxification improves most of the clinical and affective measures, but does not free from significant levels of pain intensity and headache-related disability. The partial benefit from detoxification, the severity bias and the maladaptive cognitive profile led us to believe that subgroups of chronic-relapsing migraineurs deserve a multidisciplinary approach that addresses not only the reduction of clinical severity but also specific cognitive and behavioral impairments
    corecore